Mean change in HDRS score from randomization to week 6 was larger in the levothyroxine group compared to the placebo group , with a 2.7-point difference ( decline of -7.8 [ 38.3 % ] vs -5.1 [ 25.5 % ] ; last-observation-carried-forward analysis ) .